Novartis Pharma AG: Sandoz Resolves Legacy Federal Government Civil Investigation in the U.S. Regarding Generic Drugs

Company previously disclosed settlement agreement in principle and fully provisioned for this resolution Basel, October 1, 2021 - Sandoz Inc., the U.S. subsidiary of Sandoz, has entered a settlement

Related Keywords

United States ,America ,Richard Jarvis ,Isabella Zinck ,Thomas Hungerbuehler ,Samir Shah ,Leslie Pott ,Chris Lewis ,Julie Masow ,Sloan Simpson ,Keren Haruvi ,Twitter ,Us Department Of Health ,Human Services ,Civil Division ,Office Of Inspector ,Sandoz Inc ,Novartis ,Exchange Commission ,Sandoz Us Communications ,Novartis Global Communications ,Novartis Us Communications ,Us Department Of Justice ,Sandoz Global Communications ,Inspector General ,Corporate Integrity Agreement ,Sandoz Global ,Dharma ,Sandoz ,Resolves ,Legacy ,Federal ,Government ,Civil ,Investigation ,Egarding ,Generic ,Drugs ,